To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Modified-Release Tablets 800 mg

NCT05329454 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Pain

Interventions

DRUG: Ibuprofen Tablets

Sponsor

Overseas Pharmaceuticals, Ltd.